|
1
|
Hoe AL, Royle GT and Taylor I: Breast
liver metastases-incidence, diagnosis and outcome. J R Soc Med.
84:714–716. 1991.PubMed/NCBI
|
|
2
|
Zinser JW, Hortobagyi GN, Buzdar AU, Smith
TL and Fraschini G: Clinical course of breast cancer patients with
liver metastases. J Clin Oncol. 5:773–782. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Murray T, Ward E, Samuels A,
Tiwari RC, Ghafoor A, Feuer EJ and Thun MJ: Cancer statistics,
2005. CA Cancer J Clin. 55:10–30. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Inoue K, Ogawa M, Horikoshi N, Aiba K,
Mukaiyama T, Mizunuma N, Itami S, Hirano A, Matsuoka A and
Matsumura T: Evaluation of prognostic factors for 233 patients with
recurrent advanced breast cancer. Jpn J Clin Oncol. 21:334–339.
1991.PubMed/NCBI
|
|
5
|
O'Reilly SM, Richards MA and Rubens RD:
Liver metastases from breast cancer: The relationship between
clinical, biochemical and pathological features and survival. Eur J
Cancer. 26:574–577. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Insa A, Lluch A, Prosper F, Marugan I,
Martinez-Agullo A and Garcia-Conde J: Prognostic factors predicting
survival from first recurrence in patients with metastatic breast
cancer: Analysis of 439 patients. Breast Cancer Res Treat.
56:67–78. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Goldhirsch A, Gelber RD and Castiglione M:
Relapse of breast cancer after adjuvant treatment in premenopausal
and perimenopausal women: Patterns and prognoses. J Clin Oncol.
6:89–97. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wyld L, Gutteridge E, Pinder SE, James JJ,
Chan SY, Cheung KL, Robertson JF and Evans AJ: Prognostic factors
for patients with hepatic metastases from breast cancer. Br J
Cancer. 89:284–290. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Folprecht G, Gruenberger T, Bechstein W,
Raab HR, Weitz J, Lordick F, Hartmann JT, Stoehlmacher-Williams J,
Lang H, Trarbach T, et al: Survival of patients with initially
unresectable colorectal liver metastases treated with
FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary
concept (CELIM study). Ann Oncol. 25:1018–1025. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fukumitsu N, Sugahara S, Nakayama H,
Fukuda K, Mizumoto M, Abei M, Shoda J, Thono E, Tsuboi K and
Tokuuye K: A prospective study of hypofractionated proton beam
therapy for patients with hepatocellular carcinoma. Int J Radiat
Oncol Biol Phys. 74:831–836. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mizumoto M, Okumura T, Hashimoto T, Fukuda
K, Oshiro Y, Fukumitsu N, Abei M, Kawaguchi A, Hayashi Y, Ookawa A,
et al: Proton beam therapy for hepatocellular carcinoma: A
comparison of three treatment protocols. Int J Radiat Oncol Biol
Phys. 81:1039–1045. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bush DA, Hillebrand DJ, Slater JM and
Slater JD: High-dose proton beam radiotherapy of hepatocellular
carcinoma: Preliminary results of a phase II trial.
Gastroenterology. 127 5 Suppl 1:S189–S193. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kawashima M, Furuse J, Nishio T, Konishi
M, Ishii H, Kinoshita T, Nagase M, Nihei K and Ogino T: Phase II
study of radiotherapy employing proton beam for hepatocellular
carcinoma. J Clin Oncol. 23:1839–1846. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qi WX, Fu S, Zhang Q and Guo XM: Charged
particle therapy versus photon therapy for patients with
hepatocellular carcinoma: A systematic review and meta-analysis.
Radiother Oncol. 114:289–295. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kanemoto A, Ishikawa H, Mizumoto M,
Okumura T, Hashimoto T, Oshiro Y, Fukumitsu N, Tsuboi K, Sakae T
and Sakurai H: Proton beam therapy for liver metastasis from breast
cancer: Five case reports and a review of the literature. Int Canc
Conf J. 1:pp. 210–214. 2012; View Article : Google Scholar
|
|
16
|
Fukumitsu N, Hashimoto T, Okumura T,
Mizumoto M, Tohno E, Fukuda K, Abei M, Sakae T and Sakurai H:
Investigation of the geometric accuracy of proton beam irradiation
in the liver. Int J Radiat Oncol Biol Phys. 82:826–833. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Paganetti H, Niemierko A, Ancukiewicz M,
Gerweck LE, Goitein M, Loeffler JS and Suit HD: Relative biological
effectiveness (RBE) values for proton beam therapy. Int J Radiat
Oncol Biol Phys. 53:407–421. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
National Cancer Institute, . Common
terminology criteria for adverse events (CTCAE). https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htmMay
28–2009
|
|
20
|
Adam R, Aloia T, Krissat J, Bralet MP,
Paule B, Giacchetti S, Delvart V, Azoulay D, Bismuth H and Castaing
D: Is liver resection justified for patients with hepatic
metastases from breast cancer? Ann Surg. 244:897–908. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hoffmann K, Franz C, Hinz U, Schirmacher
P, Herfarth C, Eichbaum M, Büchler MW and Schemmer P: Liver
resection for multimodal treatment of breast cancer metastases:
Identification of prognostic factors. Ann Surg Oncol. 17:1546–1554.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vlastos G, Smith DL, Singletary SE, Mirza
NQ, Tuttle TM, Popat RJ, Curley SA, Ellis LM, Roh MS and Vauthey
JN: Long-term survival after an aggressive surgical approach in
patients with breast cancer hepatic metastases. Ann Surg Oncol.
11:869–874. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Abbott DE, Brouquet A, Mittendorf EA,
Andreou A, Meric-Bernstam F, Valero V, Green MC, Kuerer HM, Curley
SA, Abdalla EK, et al: Resection of liver metastases from breast
cancer: Estrogen receptor status and response to chemotherapy
before metastasectomy define outcome. Surgery. 151:710–716. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pocard M, Pouillart P, Asselain B and
Salmon R: Hepatic resection in metastatic breast cancer: Results
and prognostic factors. Eur J Surg Oncol. 26:155–159. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Duan XF, Dong NN, Zhang T and Li Q:
Treatment outcome of patients with liver-only metastases from
breast cancer after mastectomy: A retrospective analysis. J Cancer
Res Clin Oncol. 137:1363–1370. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vogl TJ, Naguib NN, Nour-Eldin NE, Eichler
K, Zangos S and Gruber-Rouh T: Transarterial chemoembolization
(TACE) with mitomycin C and gemcitabine for liver metastases in
breast cancer. Eur Radiol. 20:173–180. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li XP, Meng ZQ, Guo WJ and Li J: Treatment
for liver metastases from breast cancer: Results and prognostic
factors. World J Gastroenterol. 11:3782–3787. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Caralt M, Bilbao I, Cortés J, Escartín A,
Lázaro JL, Dopazo C, Olsina JJ, Balsells J and Charco R: Hepatic
resection for liver metastases as part of the ‘oncosurgical’
treatment of metastatic breast cancer. Ann Surg Oncol.
15:2804–2810. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Austin-Seymour MM, Chen GT, Castro JR,
Saunders WM, Pitluck S, Woodruff KH and Kessler M: Dose volume
histogram analysis of liver radiation tolerance. Int J Radiat Oncol
Biol Phys. 12:31–35. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Emami B, Lyman J, Brown A, Coia L, Goitein
M, Munzenrider JE, Shank B, Solin LJ and Wesson M: Tolerance of
normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol
Phys. 21:109–122. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mizumoto M, Tokuuye K, Sugahara S,
Nakayama H, Fukumitsu N, Ohara K, Abei M, Shoda J, Tohno E and
Minami M: Proton beam therapy for hepatocellular carcinoma adjacent
to the porta hepatis. Int J Radiat Oncol Biol Phys. 71:462–467.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mizumoto M, Okumura T, Hashimoto T, Fukuda
K, Oshiro Y, Fukumitsu N, Abei M, Kawaguchi A, Hayashi Y, Ohkawa A,
et al: Evaluation of liver function after proton beam therapy for
hepatocellular carcinoma. Int J Radiat Oncol Biol Phys.
82:e529–e535. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hashimoto T, Tokuuye K, Fukumitsu N, Igaki
H, Hata M, Kagei K, Sugahara S, Ohara K, Matsuzaki Y and Akine Y:
Repeated proton beam therapy for hepatocellular carcinoma. Int J
Radiat Oncol Biol Phys. 65:196–202. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fukumitsu N, Okumura T, Takizawa D,
Makishima H, Numajiri H, Murofushi K, Ohnishi K, Mizumoto M, Aihara
T, Ishikawa H, et al: Proton beam therapy for metastatic liver
tumors. Radiother Oncol. 117:322–327. 2015. View Article : Google Scholar : PubMed/NCBI
|
